Mrv1909 11101919582D 18 19 0 0 0 0 999 V2000 -0.6266 -1.2035 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -1.9991 -1.7305 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 0.8416 2.9984 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1.6666 2.1734 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 0.0165 2.1734 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 0.6540 -2.9116 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.7661 -2.5311 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.1271 -1.5391 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.8416 -1.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8416 -0.3015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0409 -2.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1271 0.1108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5560 0.1108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8416 1.3483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1271 0.9359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5560 0.9359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1786 -1.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8416 2.1734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 8 1 0 0 0 0 1 17 1 0 0 0 0 2 17 2 0 0 0 0 3 18 1 0 0 0 0 4 18 1 0 0 0 0 5 18 1 0 0 0 0 6 11 2 0 0 0 0 7 11 1 0 0 0 0 7 17 1 0 0 0 0 8 9 1 6 0 0 0 8 11 1 0 0 0 0 9 10 1 0 0 0 0 10 12 2 0 0 0 0 10 13 1 0 0 0 0 12 15 1 0 0 0 0 13 16 2 0 0 0 0 14 15 2 0 0 0 0 14 16 1 0 0 0 0 14 18 1 0 0 0 0 M END > DB08574 > drugbank > FC(F)(F)C1=CC=C(C[C@H]2SC(=S)NC2=O)C=C1 > InChI=1S/C11H8F3NOS2/c12-11(13,14)7-3-1-6(2-4-7)5-8-9(16)15-10(17)18-8/h1-4,8H,5H2,(H,15,16,17)/t8-/m1/s1 > HBYVUUWMCCSRBI-MRVPVSSYSA-N > C11H8F3NOS2 > 291.313 > 290.999939878 > 1 > 26 > 25.187376177284428 > 1 > 1 > 0 > 1 > (5R)-2-sulfanylidene-5-{[4-(trifluoromethyl)phenyl]methyl}-1,3-thiazolidin-4-one > 3.15 > 3.715044426333333 > -4.56 > 0 > 2 > -1 > 13.242032824303788 > 6.748569901136131 > 29.1 > 68.61710000000001 > 3 > 1 > 8.08e-03 g/l > [(2R,3R,4S,5S)-3,4-dihydroxy-5-{4-oxo-1H,5H-pyrrolo[3,2-d]pyrimidin-7-yl}pyrrolidin-2-yl]methoxyphosphonic acid > 1 > DB08574 > experimental > (5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one $$$$